Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection

Luigi Falchetta, Arianna Montanino, Alfonso Scarpa

Open source

DOI
10.1007/s00405-026-10799-4
Published
2026-11-08
Container
European Archives of Oto-Rhino-Laryngology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00405-026-10799-4,
  title = {Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection},
  author = {Luigi Falchetta and Arianna Montanino and Alfonso Scarpa},
  year = {2026},
  journal = {European Archives of Oto-Rhino-Laryngology},
  doi = {10.1007/s00405-026-10799-4},
  url = {https://doi.org/10.1007/s00405-026-10799-4}
}

RIS

TY  - JOUR
TI  - Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection
AU  - Luigi Falchetta
AU  - Arianna Montanino
AU  - Alfonso Scarpa
PY  - 2026
JO  - European Archives of Oto-Rhino-Laryngology
DO  - 10.1007/s00405-026-10799-4
UR  - https://doi.org/10.1007/s00405-026-10799-4
ER  - 

APA

Falchetta, L., Montanino, A., & Scarpa, A. (2026). Hyperbaric oxygen therapy for sudden hearing loss in end-stage renal disease: interpreting treatment benefit and patient selection. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-026-10799-4

Source records